The CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb have agreed to voluntarily testify at a Senate hearing in February regarding high prescription drug prices in the US, negating the need for a planned subpoena. This decision came following Senator Bernie Sanders’s criticism of the executives for their initial refusal due to claimed lack of expertise.
CIOs fret over rising security concerns amid AI adoption – Cybersecurity Dive
CIOs fret over rising security concerns amid AI adoption Cybersecurity Dive
